Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

8,965 public trials 1,748 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Active, Not Recruiting

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis

NCT06106672

Conditions
AChR Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +13 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Infusion for Health Brea, California, United States
  • University of California, Irvine Orange, California, United States
  • University of California, Davis Sacramento, California, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis

NCT05403541

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Site Number -1022 Phoenix, Arizona, United States
  • Site Number -1029 Scottsdale, Arizona, United States
  • Site Number -1002 Carlsbad, California, United States
  • Site Number -1009 Irvine, California, United States
View all 93 locations
View Trial Details
Active, Not Recruiting

A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

NCT06223360

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +8 more
Locations
  • St. Joseph's Hospital and Medical Center/Barrow Neurological Institute Phoenix, Arizona, United States
  • Perseverance Research Center, LLC Scottsdale, Arizona, United States
  • Banner Sun Health Research Institute Sun City, Arizona, United States
  • The Neuron Clinic Chula Vista, California, United States
View all 47 locations
View Trial Details
Active, Not Recruiting

Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)

NCT06433219

Conditions
Adnexal Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California San Francisco - UCSF Medical Center San Francisco, California, United States
  • Centricity Research Cancer Center - DBA CRRI John B. Amos Cancer Center Research Columbus, Georgia, United States
  • University of Chicago Comprehensive Cancer Center at Silver Cross - Carolyn J. Czerkies Pavilion Chicago, Illinois, United States
View all 84 locations
View Trial Details
Active, Not Recruiting

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

NCT05485831

Conditions
Brain Diseases, Central Nervous System Diseases, Congenital Abnormalities, +25 more
Locations
  • Policlinico Sant'Orsola di Bologna Bologna, Italy
  • NPI AOU Mater Domini Università Magna Graecia Catanzaro, Italy
  • Università degli studi "G. D'annunzio" Chieti Chieti, Italy
  • Azienda Ospedaliera Universitaria Meyer Neurologia Pediatrica Florence, Italy
View all 18 locations
View Trial Details
Active, Not Recruiting

NF-1, Nutraceutical Intervention

NCT05363267

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations
  • Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions